PLANO, TEXAS – Oct. 14, 2024 – Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), will join medtech industry leaders and innovators around the world in exhibiting at the MD&M Minneapolis Exposition from Oct. 16 – 17, 2024, at the Minneapolis Convention Center. Attendees are invited to visit Integer at booth #2607.
During MD&M Minneapolis, the Integer team will be on hand to discuss capabilities and solutions to enable cardio and vascular, cardiac rhythm management, and neuromodulation products, and how the company blends technology, expertise and resources to amplify customers’ innovation and increase speed to market.
More specifically, Integer will highlight significant investments in Ireland, including a new European medical device innovation and manufacturing center in Galway, Ireland, and an 80,000 sq. ft. expansion of Integer’s guidewire manufacturing facility in New Ross, Ireland. These substantial investments help to ensure Integer’s continued ability to serve customers both locally and globally, as well as expand capacity to meet increasing customer demand for guidewires, catheters and delivery systems in the years to come. The new 67,000 sq. ft. facility in the Parkmore East area of Galway additionally supports increased customer demand for regional research, development and manufacturing.
Further amplifying the company’s presence in Ireland, Integer’s team of experts in Spiddal, Galway, additionally specialize in medical textiles, complex braiding and high-precision implant coating and covering capabilities. This extends to proprietary biomaterial technologies for implantable cardiovascular devices to enable customers’ innovation globally.
In addition, Integer will showcase its expanded design, development and manufacturing capabilities for specialty catheters, delivery systems, introducers and implantable cardiac and neurostimulation leads. This includes an expansive portfolio of OEM products including introducers, fixed and steerable guide sheaths portfolio, and implantable adaptors. These products are available for private branding, as is, or with customization. Agile design practices combined with strategic regulatory pathways allow Integer to remain competitive and customers to benefit from expedited time to market.
“Our recent investments in Ireland and continued commitment to supporting our customers’ growth underscores our unique ability to be their partner of choice for developing the next generation of lifesaving and life-enhancing medical devices,” said Payman Khales, Integer president, cardio and vascular.” By investing more than $90 million across these initiatives, Integer continues to demonstrate a global and long-term vision for the next generation of medical technologies. The future of patient care is bright, and we’re more ready than ever to lead the way in driving innovative medical advancements in years to come.”
Learn more about Integer at www.integer.net.
About Integer®
Integer Holdings Corporation (NYSE:ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. As a strategic partner of choice to medical device companies and OEMs, the Company is committed to enhancing the lives of patients worldwide by providing innovative, high-quality products and solutions. The Company's brands include Greatbatch Medical®, Lake Region Medical® and Electrochem®. Additional information is available at www.integer.net.